Evaluation of the Potential Prognostic Value of Tumor Budding in Laryngeal Carcinoma by Conventional and Immunohistochemical Staining

Overview

Journal Anal Cell Pathol (Amst)

Specialties Cell Biology
Oncology
Pathology

Date 2020 Dec 4

PMID 33274177

Citations 5

Authors

Nermine M Abd Raboh

Ossama M Mady

Sarah A Hakim

Affiliations

Soon will be listed here.

Abstract

Background: Tumor budding is a promising prognostic indicator in several cancers especially in colorectal cancer. However, only few studies have been conducted to assess and validate its prognostic value in laryngeal squamous cell carcinoma; none of which used pancytokeratin immunohistochemistry. In view of the modest results of treatment of laryngeal squamous cell carcinoma, the need of new prognostic indicators becomes of paramount importance. . We aim to evaluate tumor budding in laryngeal squamous cell carcinoma, by haematoxylin and eosin, as well as by pancytokeratin immunohistochemistry. . A retrospective study on 118 cases of laryngeal squamous cell carcinoma from archives of Pathology Lab of Ain Shams University Specialized Hospital and Ain Shams University Hospitals from January 2014 to January 2017. The ENT and histopathology reports were reviewed to determine clinicopathologic data of the patients.

Results: Tumor budding shows high statistically significant relations ( = 0.0001 for each) with important clinicopathological parameters of laryngeal carcinoma (site, grade, tumor stage, lymph node stage, lymph node extracapsular invasion, and vascular invasion). The extent of tumor budding correlated with overall survival, local recurrence disease free, and distant metastasis disease free ( = 0.001 for each). Multivariate analysis showed tumor budding to be an independent prognostic factor affecting progression-free survival. There was a moderate agreement between H&E and IHC by pancytokeratin as regards detection of budding among study cases (kappa = 0.593).

Conclusions: Tumor budding was correlated with poor prognostic clinicopathologic indicators in laryngeal squamous cell carcinoma. It is recommended to use pancytokeratin immunohistochemistry to evaluate tumor budding in laryngeal squamous cell carcinoma especially in confusing cases.

Citing Articles

Optimizing Prognostic Assessment in High-Risk Head and Neck Squamous Cell Carcinomas: The Impact of Tumor Budding and a Novel Histomorphological Scoring System.

Knebel M, Kuhn J, Korner S, Braun F, Brust L, Wemmert S Cancer Med. 2025; 14(4):e70685.

PMID: 39953822 PMC: 11829162. DOI: 10.1002/cam4.70685.

The Prognostic Significance of Tumor Budding and Cell Nest Size in Laryngeal Squamous Cell Carcinoma.

Anousha K, Shekari M, Mirzaian E, Yousefi T, Beheshti A, Lotfi M Cancer Rep (Hoboken). 2024; 7(11):e70052.

PMID: 39589172 PMC: 11590330. DOI: 10.1002/cnr2.70052.

New Tumor Budding Evaluation in Head and Neck Squamous Cell Carcinomas.

Cacchi C, Fischer H, Wermker K, Rashad A, Jonigk D, Holzle F Cancers (Basel). 2024; 16(3).

PMID: 38339338 PMC: 10854693. DOI: 10.3390/cancers16030587.

Prognostic significance of tumor budding in patients with pancreatic invasive ductal carcinoma who received neoadjuvant therapy.

Ibuki E, Kadota K, Kimura N, Ishikawa R, Oshima M, Okano K Heliyon. 2024; 10(1):e23928.

PMID: 38205326 PMC: 10777074. DOI: 10.1016/j.heliyon.2023.e23928.

An Improvised Deep-Learning-Based Mask R-CNN Model for Laryngeal Cancer Detection Using CT Images.

Sahoo P, Mishra S, Panigrahi R, Bhoi A, Barsocchi P Sensors (Basel). 2022; 22(22).

PMID: 36433430 PMC: 9697116. DOI: 10.3390/s22228834.

References

Almangush A, Salo T, Hagstrom J, Leivo I . Tumour budding in head and neck squamous cell carcinoma - a systematic review. Histopathology. 2014; 65(5):587-94. DOI: 10.1111/his.12471. View

Miyata H, Yoshioka A, Yamasaki M, Nushijima Y, Takiguchi S, Fujiwara Y . Tumor budding in tumor invasive front predicts prognosis and survival of patients with esophageal squamous cell carcinomas receiving neoadjuvant chemotherapy. Cancer. 2009; 115(14):3324-34. DOI: 10.1002/cncr.24390. View

Kanazawa H, Mitomi H, Nishiyama Y, Kishimoto I, Fukui N, Nakamura T . Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis. 2007; 10(1):41-7. DOI: 10.1111/j.1463-1318.2007.01240.x. View

Wang C, Huang H, Huang Z, Wang A, Chen X, Huang L . Tumor budding correlates with poor prognosis and epithelial-mesenchymal transition in tongue squamous cell carcinoma. J Oral Pathol Med. 2011; 40(7):545-51. PMC: 3135705. DOI: 10.1111/j.1600-0714.2011.01041.x. View

Makitie A, Almangush A, Rodrigo J, Ferlito A, Leivo I . Hallmarks of cancer: Tumor budding as a sign of invasion and metastasis in head and neck cancer. Head Neck. 2019; 41(10):3712-3718. DOI: 10.1002/hed.25872. View

Ekmekci S, Kucuk U, Kokkoz S, Cakir E, Gumussoy M . Tumor budding in laryngeal carcinoma. Indian J Pathol Microbiol. 2019; 62(1):7-10. DOI: 10.4103/IJPM.IJPM_428_17. View

Graham R, Vierkant R, Tillmans L, Wang A, Laird P, Weisenberger D . Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort. Am J Surg Pathol. 2015; 39(10):1340-6. PMC: 4567920. DOI: 10.1097/PAS.0000000000000504. View

Boxberg M, Kuhn P, Reiser M, Erb A, Steiger K, Pickhard A . Tumor Budding and Cell Nest Size Are Highly Prognostic in Laryngeal and Hypopharyngeal Squamous Cell Carcinoma: Further Evidence for a Unified Histopathologic Grading System for Squamous Cell Carcinomas of the Upper Aerodigestive Tract. Am J Surg Pathol. 2018; 43(3):303-313. DOI: 10.1097/PAS.0000000000001178. View

Ueno H, Murphy J, Jass J, Mochizuki H, Talbot I . Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology. 2002; 40(2):127-32. DOI: 10.1046/j.1365-2559.2002.01324.x. View

10.

Masuda R, Kijima H, Imamura N, Aruga N, Nakamura Y, Masuda D . Tumor budding is a significant indicator of a poor prognosis in lung squamous cell carcinoma patients. Mol Med Rep. 2012; 6(5):937-43. PMC: 3493086. DOI: 10.3892/mmr.2012.1048. View

11.

Almangush A, Bello I, Keski-Santti H, Makinen L, Kauppila J, Pukkila M . Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck. 2013; 36(6):811-8. PMC: 4229066. DOI: 10.1002/hed.23380. View

12.

Karamitopoulou E . Tumor budding cells, cancer stem cells and epithelial-mesenchymal transition-type cells in pancreatic cancer. Front Oncol. 2013; 2:209. PMC: 3539658. DOI: 10.3389/fonc.2012.00209. View

13.

Weis C, Kather J, Melchers S, Al-Ahmdi H, Pollheimer M, Langner C . Automatic evaluation of tumor budding in immunohistochemically stained colorectal carcinomas and correlation to clinical outcome. Diagn Pathol. 2018; 13(1):64. PMC: 6114534. DOI: 10.1186/s13000-018-0739-3. View

14.

Seki M, Sano T, Yokoo S, Oyama T . Histologic assessment of tumor budding in preoperative biopsies to predict nodal metastasis in squamous cell carcinoma of the tongue and floor of the mouth. Head Neck. 2015; 38 Suppl 1:E1582-90. DOI: 10.1002/hed.24282. View

15.

Bradford C, Ferlito A, Devaney K, Makitie A, Rinaldo A . Prognostic factors in laryngeal squamous cell carcinoma. Laryngoscope Investig Otolaryngol. 2020; 5(1):74-81. PMC: 7042656. DOI: 10.1002/lio2.353. View

16.

Okuyama K, Fukushima H, Naruse T, Yanamoto S, Tsuchihashi H, Umeda M . CD44 Variant 6 Expression and Tumor Budding in the Medullary Invasion Front of Mandibular Gingival Squamous Cell Carcinoma Are Predictive Factors for Cervical Lymph Node Metastasis. Pathol Oncol Res. 2018; 25(2):603-609. DOI: 10.1007/s12253-018-0529-y. View

17.

Xie N, Wang C, Liu X, Li R, Hou J, Chen X . Tumor budding correlates with occult cervical lymph node metastasis and poor prognosis in clinical early-stage tongue squamous cell carcinoma. J Oral Pathol Med. 2014; 44(4):266-72. DOI: 10.1111/jop.12242. View

18.

Lohneis P, Sinn M, Klein F, Bischoff S, Striefler J, Wislocka L . Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma. Br J Cancer. 2018; 118(11):1485-1491. PMC: 5988658. DOI: 10.1038/s41416-018-0093-y. View

19.

Elseragy A, Salo T, Coletta R, Kowalski L, Haglund C, Nieminen P . A Proposal to Revise the Histopathologic Grading System of Early Oral Tongue Cancer Incorporating Tumor Budding. Am J Surg Pathol. 2019; 43(5):703-709. DOI: 10.1097/PAS.0000000000001241. View

20.

Grigore A, Jolly M, Jia D, Farach-Carson M, Levine H . Tumor Budding: The Name is EMT. Partial EMT. J Clin Med. 2016; 5(5). PMC: 4882480. DOI: 10.3390/jcm5050051. View